Dr. Charles Landis, MD

Claim this profile

University of Washington (UW) - Harborview Medical Center (HMC) - Hepatitis and Liver Clinic

Studies Fatty Liver

Studies Nonalcoholic Steatohepatitis

5 reported clinical trials

6 drugs studied

Area of expertise

1Fatty Liver

Charles Landis, MD has run 2 trials for Fatty Liver. Some of their research focus areas include:

Stage I

Stage II

2Nonalcoholic Steatohepatitis

Charles Landis, MD has run 2 trials for Nonalcoholic Steatohepatitis. Some of their research focus areas include:

Stage I

Stage II

Affiliated Hospitals

University Of Washington (UW) - Harborview Medical Center (HMC) - Hepatitis And Liver Clinic

Harborview Medical Center - University Of Washington

Clinical Trials Charles Landis, MD is currently running

More about Charles Landis, MD

Clinical Trial Related5 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 1 Active Clinical Trial

Treatments Charles Landis, MD has experience with

Tirzepatide
HM15211
Placebo Of HM15211
Albutein 20% Injectable Solution
Placebo
Volixibat

Breakdown of trials Charles Landis, MD has run

Fatty Liver

Nonalcoholic Steatohepatitis

Non-alcoholic Fatty Liver Disease

Liver Fibrosis

Albutein for Cirrhosis

Intestinal Fibrosis

Albutein for Cirrhosis

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).

What does Charles Landis, MD specialize in?

Charles Landis, MD focuses on Fatty Liver and Nonalcoholic Steatohepatitis. In particular, much of their work with Fatty Liver has involved Stage I patients, or patients who are Stage II.

Is Charles Landis, MD currently recruiting for clinical trials?

Yes, Charles Landis, MD is currently recruiting for 1 clinical trial in Seattle Washington. If you're interested in participating, you should apply.

Are there any treatments that Charles Landis, MD has studied deeply?

Yes, Charles Landis, MD has studied treatments such as Tirzepatide, HM15211, Placebo of HM15211.

What is the best way to schedule an appointment with Charles Landis, MD?

Apply for one of the trials that Charles Landis, MD is conducting.

What is the office address of Charles Landis, MD?

The office of Charles Landis, MD is located at: University of Washington (UW) - Harborview Medical Center (HMC) - Hepatitis and Liver Clinic, Seattle, Washington 98104 United States. This is the address for their practice at the University of Washington (UW) - Harborview Medical Center (HMC) - Hepatitis and Liver Clinic.

Is there any support for travel costs?

The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.

Top trials Charles Landis, MD is currently running

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.

1045 Sansome St, Suite 321, San Francisco, CA

hello@withpower.com (415) 900-4227

Directories

Locations

Psychology Related

Treatments

Cities

···

Dr. Charles Landis, MD

University of Washington (UW) - Harborview Medical Center (HMC) - Hepatitis and Liver Clinic

Area of expertise

Affiliated Hospitals

Clinical Trials Charles Landis, MD is currently running

More about Charles Landis, MD

Other Doctors you might be interested in

Frequently asked questions

Personalize Your Experience

Save Your Preferences

Understand How the Site Is Used

Dr. Charles Landis, MD

University of Washington (UW) - Harborview Medical Center (HMC) - Hepatitis and Liver Clinic

Area of expertise

Affiliated Hospitals

Clinical Trials Charles Landis, MD is currently running

Volixibat

for Itching in Primary Sclerosing Cholangitis

The purpose of this clinical research study is to learn more about the use of the study medicine, volixibat, for the treatment of pruritus (itching) associated with Primary Sclerosing Cholangitis (PSC), and to assess the possible impact on the disease progression of PSC.

More about Charles Landis, MD

Other Doctors you might be interested in

Frequently asked questions